Pharsight

Drugs that contain Carvedilol Phosphate

1. Coreg Cr patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
USRE40000 WOODWARD Method of treatment for decreasing mortality resulting from congestive heart failure
Jun, 2015

(8 years ago)

US6022562 WOODWARD Medicinal and/or nutritional microcapsules for oral administration
Oct, 2015

(8 years ago)

USRE40000

(Pediatric)

WOODWARD Method of treatment for decreasing mortality resulting from congestive heart failure
Dec, 2015

(8 years ago)

US6022562

(Pediatric)

WOODWARD Medicinal and/or nutritional microcapsules for oral administration
Apr, 2016

(8 years ago)

US7268156 WOODWARD Carvedilol phosphate salts and/or solvates thereof, corresponding compositions and/or methods of treatment
Jun, 2023

(11 months ago)

US7268156

(Pediatric)

WOODWARD Carvedilol phosphate salts and/or solvates thereof, corresponding compositions and/or methods of treatment
Dec, 2023

(5 months ago)

US8101209 WOODWARD Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
Sep, 2025

(1 year, 3 months from now)

US8101209

(Pediatric)

WOODWARD Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
Mar, 2026

(1 year, 9 months from now)

Market Authorisation Date: 20 October, 2006

Treatment: Decreasing mortality caused by congestive heart failure; Treatment of congestive heart failure

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

How can I launch a generic of COREG CR before it's drug patent expiration?
More Information on Dosage

COREG CR family patents

Family Patents